ASPREE is the largest clinical trial ever conducted in Australia and will determine whether daily low dose aspirin prevents disease in healthy older people. The study was well-funded initially but will require additional support to complete the vital final stage of data collection and analysis. This will enable the study to answer important questions about the benefits and risks of aspirin in this age group and its effect on disability free survival.
Centre Of Research Excellence In Cognitive Health: Evidence, Intervention And Population Modelling
Funder
National Health and Medical Research Council
Funding Amount
$2,499,872.00
Summary
Cognitive health is essential for productivity at all ages. Common chronic diseases such as diabetes, and risk factors such as smoking, can reduce cognitive function and increase risk of cognitive decline. Our Centre aims to build evidence about the things that impact on cognitive health and lead to cognitive decline; to develop methods of reducing cognitive decline; and to measure the impact of cognitive impairment at the national level to inform the government on costs and planning.
Do Urban Green Spaces Help To Reduce Incidence Of Alzheimer's And Associated Risk Factors? Multilevel Longitudinal Study Of 267,153 Adults With 15 Years Of Follow-up
Funder
National Health and Medical Research Council
Funding Amount
$719,841.00
Summary
Green spaces (e.g. parks and tree canopy) may help reduce – and narrow socioeconomic inequities - in the risk of Alzheimer’s by improving mental health and cognition, promoting physical activity and social support, reducing social isolation, reducing depression, obesity, cardiometabolic disease risk and buffering harms from traffic-related air pollution. I will conduct the first large-scale longitudinal studies to examine this hypothesis across a 15-year timespan.